Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SASR
1776
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.15M | ﹤0.01% |
88,335
| – | – |
|
1777
Worthington Steel
WS
$1.63B
| $2.15M | ﹤0.01% |
64,500
+500
| +0.8% | +$16.7K |
|
|
AAT
1778
American Assets Trust
AAT
$1.25B
| $2.14M | ﹤0.01% |
95,700
| – | – |
|
|
MFA
1779
MFA Financial
MFA
$1.05B
| $2.14M | ﹤0.01% |
200,875
| – | – |
|
1780
Kennedy-Wilson Holdings
KW
$1.23B
| $2.14M | ﹤0.01% |
219,768
| – | – |
|
1781
Perimeter Solutions
PRM
$3.22B
| $2.13M | ﹤0.01% |
272,300
-17,000
| -6% | -$133K |
|
|
AIV
1782
Aimco
AIV
$1.07B
| $2.13M | ﹤0.01% |
256,384
-2,700
| -1% | -$22.4K |
|
1783
Employers Holdings
EIG
$982M
| $2.12M | ﹤0.01% |
49,800
-1,000
| -2% | -$42.6K |
|
1784
Wolverine World Wide
WWW
$2.51B
| $2.12M | ﹤0.01% |
156,700
| – | – |
|
1785
ANI Pharmaceuticals
ANIP
$2.14B
| $2.11M | ﹤0.01% |
33,100
+800
| +2% | +$50.9K |
|
1786
Vital Energy
VTLE
$647M
| $2.1M | ﹤0.01% |
46,900
+1,500
| +3% | +$67.2K |
|
1787
MGP Ingredients
MGPI
$588M
| $2.1M | ﹤0.01% |
28,200
| – | – |
|
1788
Opendoor
OPEN
$7.74B
| $2.09M | ﹤0.01% |
1,136,200
+77,800
| +7% | +$143K |
|
1789
Shoals Technologies Group
SHLS
$1.16B
| $2.09M | ﹤0.01% |
334,900
| – | – |
|
1790
Comstock Resources
CRK
$4.65B
| $2.09M | ﹤0.01% |
201,200
+9,100
| +5% | +$94.5K |
|
1791
Winmark
WINA
$1.76B
| $2.08M | ﹤0.01% |
5,900
| – | – |
|
1792
Collegium Pharmaceutical
COLL
$1.19B
| $2.07M | ﹤0.01% |
64,400
| – | – |
|
|
UMH
1793
UMH Properties
UMH
$1.28B
| $2.07M | ﹤0.01% |
129,600
+5,100
| +4% | +$81.5K |
|
1794
Nurix Therapeutics
NRIX
$684M
| $2.07M | ﹤0.01% |
+99,200
| New | +$2.07M |
|
1795
Ecovyst
ECVT
$1.05B
| $2.06M | ﹤0.01% |
230,200
+23,300
| +11% | +$209K |
|
1796
TriMas Corp
TRS
$1.59B
| $2.06M | ﹤0.01% |
80,700
-1,000
| -1% | -$25.6K |
|
1797
German American Bancorp
GABC
$1.53B
| $2.06M | ﹤0.01% |
58,350
| – | – |
|
1798
Stellar Bancorp
STEL
$1.61B
| $2.05M | ﹤0.01% |
89,262
| – | – |
|
1799
Thermon Group Holdings
THR
$826M
| $2.04M | ﹤0.01% |
66,400
| – | – |
|
|
FBRT
1800
Franklin BSP Realty Trust
FBRT
$953M
| $2.04M | ﹤0.01% |
162,033
| – | – |
|